Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy?

NeuroToxicology

Volumn 43, Issue , 2014, Pages 10-20

  Viviani, Barbara ^a   Boraso, Mariaserena ^a   Marchetti, Natalia ^a   Marinovich, Marina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Environmental contaminants; Glutamatergic system; IL 1 ; Neuroinflammation; TNF

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMPA RECEPTOR; DICHLORVOS; DIMETHOATE; GLUTAMIC ACID; GLYCOPROTEIN GP 120; INTERLEUKIN 1BETA; IONOTROPIC RECEPTOR; MANGANESE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORGANOPHOSPHATE; SARIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; EXCITATORY AMINO ACID; NEUROTOXIN;

AIR POLLUTION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CYTOKINE RESPONSE; EXCITOTOXICITY; HUMAN; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; METABOLISM; NEUROTOXICITY SYNDROMES;

ANIMALS; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; EXCITATORY AMINO ACIDS; HUMANS; NEUROTOXICITY SYNDROMES; NEUROTOXINS;

EID: 84905911087     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.03.004     Document Type: Article

References (175)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001, 2:734-744.
2. Aschner M., Aschner J.L. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev 1991, 15:333-340.
3. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007, 221:131-147.
4. Astiz M., Diz-Chaves Y., Garcia-Segura L.M. Sub-chronic exposure to the insecticide dimethoate induces a proinflammatory status and enhances the neuroinflammatory response to bacterial lypopolysaccharide in the hippocampus and striatum of male mice. Toxicol Appl Pharmacol 2013, 272:263-271.
5. Bagetta G., Corasaniti M.T., Berliocchi L., Nistico R., Giammarioli A.M., Malorni W., et al. Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience 1999, 89:1051-1066.
6. Balosso S., Ravizza T., Pierucci M., Calcagno E., Invernizzi R., Di Giovanni G., et al. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
7. Banks C.N., Lein P.J. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012, 33:575-584.
8. Banks W.A. The blood-brain barrier in psychoneuroimmunology. Neurol Clin 2006, 24:413-419.
9. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 2001, 299:536-541.
10. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., et al. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
11. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., et al. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 2005, 25:6734-6744.
12. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001, 4:702-710.
13. Biber K., Neumann H., Inoue K., Neuronal Boddeke H. 'On' and 'Off' signals control microglia. Trends Neurosci 2007, 30:596-602.
14. Binukumar B.K., Bal A., Gill K.D. Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system. Neuromolecular Med 2011, 13:251-265.
15. Block M., Elder A., Auten R., Bilbo S., Chen H., Chen J-C., et al. The outdoor air pollution and brain health workshop. Neurotoxicology 2012, 33:972-984.
16. Block M.L., Calderon-Garciduenas L. Air pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci 2009, 32:506-516.
17. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
18. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., Rothwell N.J. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 2001, 21:5528-5534.
19. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 1993, 120:89-94.
20. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996, 2:788-794.
21. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998, 273:12203-12209.
22. Calderon-Garciduenas L., Solt A.C., Henriquez-Roldan C., Torres-Jardon R., Nuse B., Herritt L., et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol 2008, 36:289-310.
23. Campbell A., Oldham M., Becaria A., Bondy S., Meacher D., Sioutas C., et al. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 2005, 26:133-140.
24. Carmen J., Rothstein J.D., Kerr D.A. Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis. Brain Res 2009, 1263:143-154.
25. Centonze D., Muzio L., Rossi S., Cavasinni F., De Chiara V., Bergami A., et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009, 29:3442-3452.
26. Chapman S., Kadar T., Gilat E. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27:277-283.
27. Chen J.C., Schwartz J. Neurobehavioral effects of ambient air pollution on cognitive performance in US adults. Neurotoxicology 2009, 30:231-239.
28. Chen Y. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology 2012, 33:391-400.
29. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988, 11:465-469.
30. Choquet D. Fast AMPAR trafficking for a high-frequency synaptic transmission. Eur J Neurosci 2010, 32:250-260.
31. Chung Y.C., Kim S.R., Park J.Y., Chung E.S., Park K.W., Won S.Y., et al. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 2011, 60:963-974.
32. Collombet J.M. Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects. Toxicol Appl Pharmacol 2011, 255:229-241.
33. Colton C., Wilcock D.M. Assessing activation states in microglia. CNS Neurol Disord Drug Targets 2010, 9:174-191.
34. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 2009, 29:2089-2102.
35. Davis D.A., Akopian G., Walsh J.P., Sioutas C., Morgan T.E., Finch C.E. Urban air pollutants reduce synaptic function of CA1 neurons via an NMDA/NO pathway in vitro. J Neurochem 2013, 127:509-519.
36. Dhote F., Carpentier P., Barbier L., Peinnequin A., Baille V., Pernot F., et al. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Toxicol Appl Pharmacol 2012, 259:195-209.
37. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., et al. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
38. Di Bona D., Candore G., Franceschi C., Licastro F., Colonna-Romano G., Camma C., et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 2009, 61:60-68.
39. Di Bona D., Plaia A., Vasto S., Cavallone L., Lescai F., Franceschi C., et al. Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res Rev 2008, 59:155-163.
40. Dillman J.F., Phillips C.S., Kniffin D.M., Tompkins C.P., Hamilton T.A., Kan R.K. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem Res Toxicol 2009, 22:633-638.
41. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997, 75:104-112.
42. Dutta K., Ghosh D., Nazmi A., Kumawat K.L., Basu A. A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS ONE 2010, 5:e9984.
43. Erikson K.M., Dobson A.W., Dorman D.C., Aschner M. Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ 2004, 334-335:409-416.
44. Farina C., Aloisi F., Meinl E. Astrocytes are active playersin cerebral innate immunity. Trends in Immunol 2007, 28:138-145.
45. Farrar W.L., Kilian P.L., Ruff M.R., Hill J.M., Pert C.B. Visualization and characterization of interleukin 1 receptors in brain. J Immunol 1987, 139:459-463.
46. Ferger B., Leng A., Mura A., Hengerer B., Feldon J. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem 2004, 89:822-833.
47. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., et al. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 2008, 28:11391-11400.
48. Ferrari C.C., Pott Godoy M.C., Tarelli R., Chertoff M., Depino A.M., Pitossi F.J. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol Dis 2006, 24:183-193.
49. Filipov N.M., Seegal R.F., Lawrence D.A. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci 2005, 84:139-148.
50. Fogal B., Hewett S.J. Interleukin-1beta: a bridge between inflammation and excitotoxicity. J Neurochem 2008, 106:1-23.
51. Fogal B., Li J., Lobner D., McCullough L.D., Hewett S.J. System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci 2007, 27:10094-10105.
52. -/- mice exposed to diesel exhaust particles. Toxicology 2007, 237:134-144.
53. Fonken L.K., Xu X., Weil Z.M., Chen G., Sun Q., Rajagopalan S., et al. Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Mol Psychiatry 2011, 16:987-995. 73.
54. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002, 22:RC216.
55. Freire C., Koifman S. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology 2012, 33:947-971.
56. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., et al. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol 1999, 93:194-202.
57. Friedman W.J. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp Neurol 2001, 168:23-31.
58. Galic M., Riazi K., Heida J., Mouihate A., Fournier N., Spencer S., et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008, 28:6904-6917.
59. Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front Neuroendocrinol 2012, 33:116-125.
60. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 1989, 23:109-116.
61. Gardoni F., Boraso M., Zianni E., Corsini E., Galli C.L., Cattabeni F., et al. Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinflammation 2011, 8:14.
62. Gavin C.E., Gunter K.K., Gunter T.E. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 1999, 20:445-453.
63. Grauer E., Chapman S., Rabinovitz I., Raveh L., Weissman B.A., Kadar T., et al. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits. Toxicol Appl Pharmacol 2008, 227:265-274.
64. Griffin W.S., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995, 54:276-281.
65. Groc L., Bard L., Choquet D. Surface trafficking of N-methyl-d-aspartate receptors: physiological and pathological perspectives. Neuroscience 2009, 158:4-18.
66. Hagan P., Poole S., Bristow A.F., Tilders F., Silverstein F.S. Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain. J Neurochem 1996, 67:2215-2218.
67. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010, 11:682-696.
68. Harry G.J., Lefebvre d'Hellencourt C., McPherson C.A., Funk J.A., Aoyama M., Wine R.N. Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons. J Neurochem 2008, 106:281-298.
69. Hartz A.M., Bauer B., Block M.L., Hong J.S., Miller D.S. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. Faseb J 2008, 22:2723-2733.
70. He P., Liu Q., Wu J., Shen Y. Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. Faseb J 2012, 26:334-345.
71. He P., Zhong Z., Lindholm K., Berning L., Lee W., Lemere C., et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 2007, 178:829-841.
72. Henderson R.F., Barr E.B., Blackwell W.B., Clark C.R., Conn C.A., Kalra R., et al. Response of rats to low levels of sarin. Toxicol Appl Pharmacol 2002, 184:67-76.
73. Huang Y., Smith D.E., Ibanez-Sandoval O., Sims J.E., Friedman W.J. Neuron-specific effects of interleukin-1beta are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neurosci 2011, 31:18048-18059.
74. Jander S., Schroeter M., Stoll G. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol 2000, 109:181-187.
75. Johnson E.A., Kan R.K. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation 2010, 7:40.
76. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
77. Keifer J., Zheng Z. AMPA receptor trafficking and learning. Eur J Neurosci 2010, 32:269-277.
78. Kettunen J., Lanki T., Tiittanen P., Aalto P.P., Koskentalo T., Kulmala M., et al. Associations of fine and ultrafine particulate air pollution with stroke mortality in an area of low air pollution levels. Stroke 2007, 38:918-922.
79. Kim H., Shin A., Thayer S. Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol Pharmacol 2011, 80:357-366.
80. Kinouchi K., Brown G., Pasternak G., Donner D.B. Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem Biophys Res Commun 1991, 181:1532-1538.
81. Korherr C., Hofmeister R., Wesche H., Falk W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 1997, 27:262-267.
82. Kozhemyakin M., Rajasekaran K., Kapur J. Central cholinesterase inhibition enhances glutamatergic synaptic transmission. J Neurophysiol 2010, 103:1748-1757.
83. Kraft A., Harry G. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 2011, 8:2980-3018.
84. Lai A.Y., Swayze R.D., El-Husseini A., Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 2006, 175:97-106.
85. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., Blanchet G. Medical management of organophosphate-induced seizures. J Physiol Paris 1998, 92:369-373.
86. Lau C.G., Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007, 8:413-426.
87. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 1998, 10:1188-1195.
88. Lee E.S., Sidoryk M., Jiang H., Yin Z., Aschner M. Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem 2009, 110:530-544.
89. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
90. Levesque S., Surace M., McDonald J., Block M. Air pollution & the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease. J Neuroinflammation 2011, 8:105.
91. Levesque S., Taetzsch T., Lull M.E., Kodavanti U., Stadler K., Wagner A., et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ Health Perspect 2011, 119:1149-1155.
92. Liccione J.J., Maines M.D. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 1988, 247:156-161.
93. Lisabeth L.D., Escobar J.D., Dvonch J.T., Sanchez B.N., Majersik J.J., Brown D.L., et al. Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann Neurol 2008, 64:53-59.
94. Liu C., Chalmers D., Maki R., De Souza E.B. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J Neuroimmunol 1996, 66:41-48.
95. Liu M., Cai T., Zhao F., Zheng G., Wang Q., Chen Y., et al. Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism. Neurotox Res 2009, 16:42-49.
96. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996, 16:932-940.
97. Maier S.F. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 2003, 17:69-85.
98. Mandolesi G., Musella A., Gentile A., Grasselli G., Haji N., Sepman H., et al. Interleukin-1beta alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci 2013, 33:12105-12121.
99. Mangano E.N., Litteljohn D., So R., Nelson E., Peters S., Bethune C., et al. Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging 2012, 33:1411-1426.
100. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009, 33:355-366.
101. McCoy M.K., Martinez T.N., Ruhn K.A., Szymkowski D.E., Smith C.G., Botterman B.R., et al. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci 2006, 26:9365-9375.
102. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997, 21:559-579.
103. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990, 11:379-387.
104. Meyer U., Schwarz M.J., Muller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 2011, 132:96-110.
105. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001, 21:2808-2819.
106. Mishra A., Kim H.J., Shin A.H., Thayer S.A. Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol 2012, 7:571-578.
107. Mitra S., Chakrabarti N., Bhattacharyya A. Differential regional expression patterns of alpha-synuclein, TNF-alpha, and IL-1β and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment. J Neuroinflammation 2011, 8:163.
108. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol 2012, 7:42-59.
109. Morgan T.E., Davis D.A., Iwata N., Tanner J.A., Snyder D., Ning Z., et al. Glutamatergic neurons in rodent models respond to nanoscale particulate urban air pollutants in vivo and in vitro. Environ Health Perspect 2011, 119:1003-1009.
110. Ni M., Li X., Yin Z., Sidoryk-Wegrzynowicz M., Jiang H., Farina M., et al. Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 2011, 59:810-820.
111. Noe F.M., Polascheck N., Frigerio F., Bankstahl M., Ravizza T., Marchini S., et al. Pharmacological blockade of IL-1beta/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 2013, 59:183-193.
112. Pattarini R., Pittaluga A., Raiteri M. The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-d-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience 1998, 87:147-157.
113. Pearson V.L., Rothwell N.J., Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 1999, 25:311-323.
114. Pope C., Karanth S., Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ Toxicol Pharmacol 2005, 19:433-446.
115. Potter M., Figuera-Losada M., Rojas C., Slusher B. Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol 2013, 8:594-607.
116. Power M.C., Weisskopf M.G., Alexeeff S.E., Coull B.A., Spiro A., Schwartz J. Traffic-related air pollution and cognitive function in a cohort of older men. Environ Health Perspect 2011, 119:682-687.
117. Pribiag H., Stellwagen D. TNF-alpha downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABAA receptors. J Neurosci 2013, 33:15879-15893.
118. Pugh C.R., Johnson J.D., Martin D., Rudy J.W., Maier S.F., Watkins L.R. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res 2000, 861:8-15.
119. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012, 12:623-635.
120. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
121. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992, 29:243-246.
122. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends in Neurosci 1997, 20:570-577.
123. Rohlman D.S., Anger W.K., Lein P.J. Correlating neurobehavioral performance with biomarkers of organophosphorous pesticide exposure. Neurotoxicology 2011, 32:268-276.
124. Rossi S., Furlan R., De Chiara V., Motta C., Studer V., Mori F., et al. Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol 2012, 71:76-83.
125. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
126. Saïd-Sadier N., Ojcius D. Alarmins, inflammasomes and immunity. Biomed J 2012, 35:437-449.
127. Salter M.W., Kalia L.V. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004, 5:317-328.
128. Santello M., Volterra A. TNFalpha in synaptic function: switching gears. Trends Neurosci 2012, 35:638-647.
129. Santos M.D., Pereira E.F., Aracava Y., Castro N.G., Fawcett W.P., Randall W.R., et al. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. J Pharmacol Exp Ther 2003, 304:254-265.
130. Schneider J., Kaaden O., Copeland T.D., Oroszlan S., Hunsmann G. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol 1986, 67(Pt 11):2533-2538.
131. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 2010, 6:405-410.
132. Shaftel S.S., Kyrkanides S., Olschowka J.A., Miller J.N., Johnson R.E., O'Banion M.K. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Investig 2007, 117:1595-1604.
133. Shibakawa Y.S., Sasaki Y., Goshima Y., Echigo N., Kamiya Y., Kurahashi K., et al. Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth 2005, 95:803-810.
134. Shiozaki T., Hayakata T., Tasaki O., Hosotubo H., Fuijita K., Mouri T., et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005, 23:406-410.
135. Sidoryk-Wegrzynowicz M., Aschner M. Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacol Toxicol 2013, 14:23.
136. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., McMahan C.J., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988, 241:585-589.
137. Smith J., Das A., Ray S., Banik N. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012, 87:10-20.
138. Spadoni F., Stefani A., Morello M., Lavaroni F., Giacomini P., Sancesario G. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res 2000, 135:544-551.
139. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. Faseb J 2002, 16:1474-1476.
140. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005, 25:3219-3228.
141. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 1995, 15:3468-3474.
142. Svensson I., Waara L., Cassel G. Effects of HI 6, diazepam and atropine on soman-induced IL-1 beta protein in rat brain. Neurotoxicology 2005, 26:173-181.
143. Svensson I., Waara L., Johansson L., Bucht A., Cassel G. Soman-induced interleukin-1 beta mRNA and protein in rat brain. Neurotoxicology 2001, 22:355-362.
144. Swiston J.R., Davidson W., Attridge S., Li G.T., Brauer M., van Eeden S.F. Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur Respir J 2008, 32:129-138.
145. Takaki J., Fujimori K., Miura M., Suzuki T., Sekino Y., Sato K. l-Glutamate released from activated microglia downregulates astrocytic l-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular l-glutamate concentration in neuroinflammation. J Neuroinflammation 2012, 9:275.
146. Tamagawa E., van Eeden S.F. Impaired lung function and risk for stroke: role of the systemic inflammation response. Chest 2006, 130:1631-1633.
147. Tarkowski E., Andreasen N., Tarkowski A., Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003, 74:1200-1205.
148. Tarkowski E., Rosengren L., Blomstrand C., Jensen C., Ekholm S., Tarkowski A. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 1999, 30:321-327.
149. Tin Tin Win S., Mitsushima D., Yamamoto S., Fukushima A., Funabashi T., Kobayashi T., et al. Changes in neurotransmitter levels and proinflammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol Appl Pharmacol 2008, 226:192-198.
150. Tolosa L., Caraballo-Miralles V., Olmos G., Llado J. TNF-alpha potentiates glutamate-induced spinal cord motoneuron death via NF-kappaB. Mol Cell Neurosci 2011, 46:176-186.
151. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992, 31:349-360.
152. Verity M.A. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 1999, 20:489-497.
153. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999, 19:5054-5065.
154. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
155. Viviani B., Boraso M., Valero M., Gardoni F., Marco E.M., Llorente R., et al. Early maternal deprivation immunologically primes hippocampal synapses by redistributing interleukin-1 receptor type I in a sex dependent manner. Brain Behav Immun 2014, 35:135-143.
156. Viviani B., Corsini E., Binaglia M., Galli C.L., Marinovich M. Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience 2001, 107:51-58.
157. Viviani B., Corsini E., Galli C.L., Marinovich M. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998, 150:271-276.
158. Viviani B., Gardoni F., Bartesaghi S., Corsini E., Facchi A., Galli C.L., et al. Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem 2006, 281:30212-30222.
159. Wahner A.D., Sinsheimer J.S., Bronstein J.M., Ritz B. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch Neurol 2007, 64:836-840.
160. Wang C.X., Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002, 67:161-172.
161. Wang S., Cheng Q., Malik S., Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 2000, 292:497-504.
162. Wang Y., Wang B., Zhu M.T., Li M., Wang H.J., Wang M., et al. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011, 205:26-37.
163. Weuve J., Puett R.C., Schwartz J., Yanosky J.D., Laden F., Grodstein F. Exposure to particulate air pollution and cognitive decline in older women. Arch Intern Med 2012, 172:219-227.
164. Wheeler D., Knapp E., Bandaru V.V., Wang Y., Knorr D., Poirier C., et al. Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem 2009, 109:1237-1249.
165. Win-Shwe T.T., Yamamoto S., Fujitani Y., Hirano S., Fujimaki H. Nanoparticle-rich diesel exhaust affects hippocampal-dependent spatial learning and NMDA receptor subunit expression in female mice. Nanotoxicology 2012, 6:543-553.
166. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-680. discussion 81.
167. Yang L., Lindholm K., Konishi Y., Li R., Shen Y. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci 2002, 22:3025-3032.
168. Yang S., Liu Z.W., Wen L., Qiao H.F., Zhou W.X., Zhang Y.X. Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission. Brain Res 2005, 1034:172-179.
169. Ye L., Huang Y., Zhao L., Li Y., Sun L., Zhou Y., et al. IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem 2013, 125:897-908.
170. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25:181-213.
171. Zaja-Milatovic S., Gupta R.C., Aschner M., Milatovic D. Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol 2009, 240:124-131.
172. Zhang P., Lokuta K.M., Turner D.E., Liu B. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J Neurochem 2010, 112:434-443.
173. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci 2009, 107:156-164.
174. Zhao M.L., Kim M.O., Morgello S., Lee S.C. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 2001, 115:182-191.
175. Zimmer L.A., Ennis M., Shipley M.T. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J Comp Neurol 1997, 378:482-492.